TLR4 and neoplasm: Intratumoral delivery of mRNA encoding the costimulatory molecule CD70, the CD40 ligand and constitutively active Toll-like receptor 4 (TriMix mRNA) has shown systemic therapeutic antitumor immunity in various mouse cancer models through modulating the activity of tumor-infiltrating dendritic cells (TiDCs) [40].